Abstract
Hypertension contributes to a quarter of all-cause mortality in China. The Chinese government has put forward aims to control and prevent hypertension, and China CDC and other professional public health institutions have carried out a series of related efforts including the promotion of related policies and legislation, the improvement of modifiable risk factors of hypertension in the population, and promoting the National Primary Public Health Services to discover and manage patients with hypertension. China CDC has conducted multiple hypertension-related campaigns such as advocating for salt reduction, weight loss, and increased physical activity. Additionally, on behalf of the Chinese government, China CDC has organized and carried out the construction of national demonstration areas for the comprehensive prevention and control of chronic diseases. As of 2020, 488 national demonstration areas have been established, covering 17.1% of all counties and districts. In these areas, the lifestyle and health literacy of the population and community-based hypertension management measures have been improved. The Healthy China 2030 calls for a transition from disease treatment to a focus on health, which requires a strategy of hypertension prevention and control that focuses on the whole population rather than on high-risk populations. The Primary Health Care, Medicine and Health Promotion Law was officially implemented on June 1, 2020 and provides the legal basis for this strategy change in the prevention and control of hypertension. Ongoing public health legislation should involve non-communicable diseases such as hypertension in addition to communicable diseases.
Highlights
This study aimed to explore the challenges and opportunities of hypertension prevention and control by reviewing the work of the China CDC in changing strategies, lifestyle interventions, and patient management
In 2018, China CDC suggested that the prevention and control of hypertension must change from a highrisk population strategy led by the health department to a population-wide strategy that includes all parts of society [3]; risk factors of hypertension such as high salt intake, overweight or obesity, and insufficient exercise should be addressed while strengthening screening and management for hypertension
The Primary Health Care, Medicine and Health Promotion Law, officially implemented on June 1, 2020, has established health promotion as a legal provision for the first time in China [5]. This legislation provides the legal foundation for changing the hypertension prevention and control strategy from one focusing on high-risk populations to a strategy that includes the whole population
Summary
The Chinese government has put forward aims to control and prevent hypertension, and China CDC and other professional public health institutions have carried out a series of related efforts including the promotion of related policies and legislation, the improvement of modifiable risk factors of hypertension in the population, and promoting the National Primary Public Health Services to discover and manage patients with hypertension. As of 2020, 488 national demonstration areas have been established, covering 17.1% of all counties and districts In these areas, the lifestyle and health literacy of the population and community-based hypertension management measures have been improved. This study aimed to explore the challenges and opportunities of hypertension prevention and control by reviewing the work of the China CDC in changing strategies, lifestyle interventions, and patient management
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have